The American public has a right to know where our generic medicines are made, and to be assured of their quality.
Nearly all (>90% of) generic pills, tablets and capsules are currently manufactured overseas, most of them in India and China. The COVID pandemic has taught us that we are one strategic event away from losing our access to life sustaining drugs.
A reliable supply chain should be of national strategic interest, to safeguard our ability to provide access to drugs for managing chronic health conditions.
High-quality generics can be supplied at ethical margin, made in the USA by Americans, for Americans.